TCT Directors
TCT Co-Directors
To submit an interview request with one of these experts, please contact:
Irma Damhuis
Director, External Relations
Tel: 212-851-9187
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Judy Romero
Senior Communications Associate
Tel: 212-851-9311
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Martin B. Leon, MD, is Founder and Chairman Emeritus and Co-Director, Medical Research and Education Division of the Cardiovascular Research Foundation. Dr. Leon is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Associate Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Leon is also the Founder and Director of Transcatheter Cardiovascular Therapeutics (TCT), the largest meeting in the world dedicated to interventional vascular therapy.
An internationally renowned interventional cardiologist, Dr. Leon has made significant contributions to almost every major development in the field of interventional vascular therapy over the past 20 years. He has performed more than 7,000 interventional procedures and has coauthored over 1,100 publications.
Dr. Leon has been a national principal investigator of more than 20 major clinical interventional trials in the United States. He is a featured lecturer at international symposia, most recently focusing on drug-eluting stents and transcatheter valve therapy. Dr. Leon has also received six international career achievement awards and was recently awarded an honorary degree from the University of Athens, Greece.
Dr. Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York, NY. He also has served as Director of Cardiovascular Research at the Washington Cardiology Center of the Washington Hospital Center and as Clinical Professor of Medicine at Georgetown University Medical Center, both in Washington, DC. He was a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung, and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of both the Washington Cardiology Center and the Cardiology Research Foundation, both in Washington, DC.
Dr. Leon received his medical degree from the Yale School of Medicine, New Haven, CT, and completed his internship, residency in internal medicine, and fellowship training in cardiology at the Yale-New Haven Hospital.
Gregg W. Stone, MD, FACC, FSCAI, is Co-Director, Medical Research and Education Division of the Cardiovascular Research Foundation. Dr. Stone is also a Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone has served as the national or international principal investigator for more than 40 multicenter randomized trials, has authored more than 1,000 book chapters, manuscripts, and abstracts published in peer-reviewed literature, and has delivered thousands of lectures around the world.
Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction, drug-eluting stents, adjunct pharmacology, percutaneous heart valves, new device angioplasty (including distal embolic protection), thrombectomy, vascular brachytherapy and stent grafts, intravascular ultra-sound imaging, saphenous vein graft therapies, chronic total occlusions, vulnerable plaque, contrast nephropathy, clinical trial design, and regulatory issues.
Along with Martin B. Leon, MD, Dr. Stone is Director of Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiology and vascular medicine, directs the Annual Interventional Cardiology Fellows Course, and co-directs several other annual courses, such as the International Chronic Total Occlusion Summit, Transcatheter Valve Therapies, and the CRF symposium at the American College of Cardiology Annual Scientific Session/i2 Summit.
Dr. Stone's medical practice is devoted to interventional cardiology at NewYork-Presbyterian Hospital/Columbia University Medical Center. He previously held similar positions at Lenox Hill Hospital in New York, NY, and the Washington Hospital Center in Washington, DC. Previously, Dr. Stone was the Director of Interventional Cardiology at the Heart and Vascular Institute at El Camino Hospital in Mountain View, CA, and Stanford University Medical Center in Stanford, CA.
Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA, under Jeremy Swan, MD, and a subsequent dedicated fellowship in advanced coronary angioplasty with Geoffrey O. Hartzler, MD, in Kansas City, MO. Dr. Stone is board certified in interventional cardiology, cardiovascular diseases, and internal medicine.
George D. Dangas, MD, PhD, is the Director of Academic Affairs and Investigational Pharmacology at the Cardiovascular Research Foundation. Dr. Dangas is also Associate Professor of Medicine, Division of Cardiology at Columbia University College of Physicians and Surgeons, as well as Director of Postgraduate Training at the Center for Interventional Vascular Therapy and Program Director for Interventional Cardiology Fellowships, both at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Dr. Dangas is a leading authority in the performance of nonsurgical cardiac and vascular interventions (eg, stent, angioplasty, atherectomy) using both established and novel techniques to prevent and dissolve thrombosis in the coronary and peripheral arteries, as well as an authority in advanced imaging of the heart and blood vessels. He is currently serving as the American College of Cardiology-appointed co-chair of the American College of Cardiology Interventional Cardiology Symposium and is a trustee for the Society for Cardiovascular Angiography and Interventions (SCAI). He has been a Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium since 1999.
Dr. Dangas completed medical and postgraduate studies at the National Kapodistrian University in Athens, Greece. He finished his internship and residency in internal medicine at Miriam Hospital and Brown University in Providence, Rhode Island, and cardiovascular disease and interventional cardiology fellowships at The Mount Sinai Hospital and The Mount Sinai School of Medicine, New York, NY. He has been certified by the American Board of Internal Medicine in internal medicine, cardiovascular disease, and interventional cardiology, and has been elected Fellow of 6 national and international societies (American Heart Association, American College of Cardiology, American College of Chest Physicians, European Society of Cardiology, SCAI, American College of Physicians-American Society of Internal Medicine).
William A. Gray, MD, is Co-Director of the Transcatheter Cardiovascular Therapeutics (TCT). He is also an Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and Director of Endovascular Services at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. An interventional cardiologist, Dr. Gray was previously the Director of Endovascular Care for the Swedish Heart Institute (SHI) and a principal partner with First Hill Cardiology—an affiliated clinic of SHI. As Director of Endovascular Care, Dr. Gray was responsible for program development, research in cardiovascular disease, and physician education. Prior to joining the Swedish Heart Institute, Dr. Gray had been Vice Chairman of the Cardiology Division at Presbyterian Hospital in Albuquerque, NM, and a founding member of the Heart Hospital of New Mexico.
Dr. Gray is board certified in internal medicine, cardiology and interventional cardiology, and specializes in coronary and peripheral arterial disease. He has particular interest in new, non-surgical modalities for stroke prevention (carotid stenting and patent foramen ovale—PFO—closure), the nonsurgical treatment of abdominal aortic aneurysm, and research into preventing the reoccurrence of disease following successful angioplasty or stenting. Dr. Gray has been principal investigator for clinical and commercial trials, and a consultant and device/procedure proctor for medical corporations. He is a journal reviewer for the Journal of the American Medical Association and the Annals of Emergency Medicine, and is routinely asked to speak at national and international conferences. He is also a member of several professional organizations, including the International Society of Cardiovascular Interventionists, American College of Cardiology, American Heart Association, and the American College of Physicians.
Dr. Gray holds a bachelor’s degree in chemistry from Dickinson College in Carlisle, PA, and his M.D. degree from Temple University’s School of Medicine in Philadelphia. Dr. Gray’s postgraduate training included an internship and residency in internal medicine at Brown University/Rhode Island Hospital in Providence, RI, where he also completed a clinical/research fellowship in cardiology and an interventional fellowship in cardiology.
Roxana Mehran, MD, is Chief Scientific Officer at the Clinical Trials Center at the Cardiovascular Research Foundation. She is also Associate Professor of Medicine, Division of Cardiology at Columbia University College of Physicians and Surgeons, as well as Director of Outcomes Research, Data Coordination and Analysis at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Dr. Mehran is a practicing interventional cardiologist specializing in nonsurgical cardiac procedures (eg, stenting, angioplasty, atherectomy) that use both established and novel techniques to prevent recurrence and dissolve thrombosis in the coronary arteries, as well as in advanced imaging of the heart and blood vessels. She currently serves as a member of the American Heart Association Cardiac Catheterization Committee and has been a course co-director for the annual Transcatheter Cardiovascular Therapeutics (TCT) conference since 1997.
Dr. Mehran has a long-standing research interest in cardiovascular topics, including intravascular ultrasound, renal failure, women’s health, angioplasty, and coronary stenting. She has written over 300 publications on these topics in addition to multiple book chapters in several textbooks on interventional cardiology.
Dr. Mehran completed her training in internal medicine at the University of Connecticut, Storrs, CT, where she was also Chief Medical Resident. She completed her fellowships in cardiovascular disease and interventional cardiology at The Mount Sinai Hospital and The Mount Sinai School of Medicine, New York, NY. Dr. Mehran is board certified in internal medicine, cardiovascular diseases, and interventional cardiology and is an elected fellow of 6 major societies (American Heart Association, American College of Cardiology, American College of Physicians, American College of Chest Physicians, European Society of Cardiology, and Society of Cardiac Angiography and Interventions.)
Gary S. Mintz, MD, is Chief Medical Officer of the Cardiovascular Research Foundation, Editor-in-Chief of TCTMD.com, and a Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). Dr. Mintz has extensive experience in both interventional cardiology and cardiac ultrasound and is an expert in the area of cardiovascular imaging. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program, which has studied over 30,000 patients using intravascular ultrasound and has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis.
He is the author of over 575 articles, 50 book chapters, and 550 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular ultrasound. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound, the definitive work in the field.
Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University, in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty (with a joint appointment in the Department of Diagnostic Radiology) in 1978 and was ultimately promoted to Professor of Medicine in 1987. His administrative appointments there included Director of the Cardiac Ultrasound Laboratory, Director of the Coronary Care Unit, and Director of the Cardiology Fellowship Training Program. He received teaching awards from both the Department of Medicine Residency and Cardiology Fellowship Training Programs.
